CoolSculpting Chevy Chase

Allergan, the popular manufacturer of Juvederm filler and Botox, recently announced the purchase of ZELTIQ, the company that manufactures the body contouring procedure, CoolSculpting.
CoolSculpting has become wildly popular among Hollywood elites and regular everyday folks who are looking for an effective way to freeze their fat. The CoolSculpting procedure is the world’s No. 1 non-invasive fat-reduction procedure and Allergan is betting that it could be the next Botox.
“The acquisition of ZELTIQ is highly complementary and strategic to Allergan. By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings we are creating a world-class aesthetics business,” said Brent Saunders, Chairman and CEO of Allergan.
The innovative CoolSculpting fat-freezing procedure was cleared by the Food and Drug Administration in 2010.
According to ZELTIQ, CoolSculpting is an innovative way to contour your body by freezing unwanted fat away with no surgery or downtime.
With more than 3.5 million CoolSculpting treatments performed worldwide, people everywhere are experiencing real results, thanks to the one-of-a-kind CoolSculpting procedure.
“Body contouring in our view is where facial injectables were 10 years ago,” said Allergan Chief Commercial Officer Bill Meury, comparing CoolSculpting to Allergan’s popular Botox injections. “It has excellent future growth prospects.”
Men are also being targeted for body contouring procedures, especially for areas like the chest and stomach.
“One treatment can be come a gateway to other aesthetic treatments,” said Bloomberg Intelligence analyst Elizabeth Krutoholow.
“Demand for both procedures is high and this is similar to pouring more gas on the fire,” Allergan Chief Commercial Officer Bill Meury said in regards to injectables and body contouring.